Skip Navigation

Schizophrenia Bulletin 2003 29(4):851-858;
© 2003 by Oxford University Press and the Maryland Psychiatric Research Center (MPRC)
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by McGlashan, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGlashan, T. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press

Commentary: Progress, Issues, and Implications of Prodromal Research: An Inside View

Thomas H. McGlashan, M.D., Executive Director and Psychiatrist-in-Chief
Department of Psychiatry, Yale University School of Medicine New Haven, CT

This issue of the Schizophrenia Bulletin focuses around research in the prodromal phase of severe mental illness, largely schizophrenia. The years since the last Bulletin issue on early detection and intervention have witnessed success at identifying the prodrome prospectively, positive initial data about treating prodromal symptoms and delaying psychosis onset, and hopeful data about elucidating the pathophysiology of psychosis through the prodrome. In this overview I will comment on some of the opportunities and challenges generated by this new line of research. Themes include the recruitment of prodromal subjects, characteristics of prodromal samples thus far collected, the process of conversion to psychosis in these samples, minimizing false positive prodromal subjects, dosing of drug treatments in prodromal clinical trials, treatment practice implications of prodromal research, defining conversion to psychosis prospectively, and screening, assessing, and naming the prodrome. It is concluded that prodromal research holds much promise but will require the formal collaboration of many investigators and the availability of resources for sustained efforts to recruit what amounts to an incidence sample.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Br. J. PsychiatryHome page
N. Crumlish, P. Whitty, M. Clarke, S. Browne, M. Kamali, M. Gervin, O. McTigue, A. Kinsella, J. L Waddington, C. Larkin, et al.
Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis
The British Journal of Psychiatry, January 1, 2009; 194(1): 18 - 24.
[Abstract] [Full Text] [PDF]

Home page
 Schizophr BullHome page
C. U. Correll, J. B. Penzner, A. M. Frederickson, J. J. Richter, A. M. Auther, C. W. Smith, J. M. Kane, and B. A. Cornblatt
Differentiation in the Preonset Phases of Schizophrenia and Mood Disorders: Evidence in Support of a Bipolar Mania Prodrome
Schizophr Bull, May 2, 2007; (2007) sbm028v1.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
T. H. McGlashan, R. B. Zipursky, D. Perkins, J. Addington, T. Miller, S. W. Woods, K. A. Hawkins, R. E. Hoffman, A. Preda, I. Epstein, et al.
Randomized, Double-Blind Trial of Olanzapine Versus Placebo in Patients Prodromally Symptomatic for Psychosis
Am J Psychiatry, May 1, 2006; 163(5): 790 - 799.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.